4-[5-(Furan-2-yl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamid

被引:2
|
作者
Asiri, Abdullah M. [1 ,2 ]
Faidallah, Hassan M. [1 ]
Alamry, Khalid A. [1 ]
Ng, Seik Weng [1 ,3 ]
Tiekink, Edward R. T. [3 ]
机构
[1] King Abdulaziz Univ, Fac Sci, Chem Dept, Jeddah 80203, Saudi Arabia
[2] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah, Saudi Arabia
[3] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia
关键词
D O I
10.1107/S1600536812011920
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
In the title compound, C14H10F3N3O3S, there are significant twists in the molecule, as seen in the values of the dihedral angles between the pyrazole ring and each of the furan [31.1 (2)degrees] and benzene rings [55.58 (10)degrees]. The amino N atom occupies a position almost normal to the benzene ring [NS- C-ar-C-ar (ar = aromatic) torsion angle = 83.70 (19)degrees]. One amino H atom forms a hydrogen bond to the tricoordinate pyrazole N atom and the other interacts with a sulfonamide O atom, forming a supramolecular chain along [010]. The chains are consolidated into a supramolecular layers via C - H center dot center dot center dot O interactions involving the second sulfonamide O atom; layers stack along [10 (1) over bar]. The furan ring was found to be disordered over two diagonally opposite orientations of equal occupancy.
引用
收藏
页码:O1168 / +
页数:11
相关论文
共 50 条
  • [1] Crystal structures of (5RS)-(Z)-4-[5-(furan-2-yl)-3 phenyl-4,5-dihydro-1H-pyrazol-1-yl]-4-oxobut-2enoic acid and (5RS)-(Z)-4-[5-(furan-2-yl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxobut-2-enoic acid
    Borisova, Kseniya K.
    Toze, Flavien A. A.
    Yagafarov, Nniyaz Z.
    Zubkov, Fedor I.
    Dorovatovskii, Pavel V.
    Zuhavichus, Yan V.
    Khrustalev, Victor N.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2016, 72 : 1557 - +
  • [2] 1-{3-(4-Methylphenyl)-5-[5-(2-nitrophenyl)furan-2-yl]-4,5-dihydro-1H-pyrazol-1-yl}ethanone
    Vinutha, N.
    Kumar, S. Madan
    Jois, B. S. Vidyashree
    Balakrishna, Kalluraya
    Lokanath, N. K.
    Revannasiddaiah, D.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1528 - +
  • [3] 4-(5-Phenyl-3-trifluoromethyl-1H-pyrazol-1-yl)benzenesulfonamide
    Asiri, Abdullah M.
    Al-Youbi, Abdulrahman O.
    Faidallah, Hassan M.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2424 - U1087
  • [4] (Z)-4-[(Ethylamino)(furan-2-yl)methylidene]-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one
    Li, Li-Nan
    Zhang, Wei-Guo
    Huang, Shan-Shan
    Li, Chuan-Xun
    Wang, Shou-Yu
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1277 - +
  • [5] (Furan-2-yl)(5-hydroxy-3-methyl-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)methanone
    Kargar, Hadi
    Kia, Reza
    Moghadamm, Majid
    Tahir, Muhammad Nawaz
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O367 - U641
  • [6] 2-Chloro-4-(1H-pyrazol-1-yl)-5-(trifluoromethyl)pyrimidine
    Bunker, Kevin D.
    Moore, Curtis
    Palmer, Cynthia L.
    Rheingold, Arnold L.
    Yanovsky, Alex
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O1448 - U1742
  • [7] 5-[5-(4-Methoxyphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]-2-sulfamoylbenzyl propionate:: a novel 1,5-diraylpyrazole class of COX-2 inhibitor
    Vyas, K
    Sivalakshmidevi, A
    Singh, SK
    Rao, YK
    Reddy, GO
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2003, 59 : O1731 - O1732
  • [8] 5-(furan-2-yl)-1,3,4-oxadiazole-2(3H)-thione
    Öztürk, S
    Akkurt, M
    Cansiz, A
    Çetin, A
    Sekerci, M
    Heinemann, FW
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2004, 60 : O322 - O323
  • [9] 4-[5-(4-Chlorophenyl)-3-methyl-1H-pyrazol-1-yl]benzenesulfonamide
    Farrukh, Muhammad A.
    Mohamed, Shaaban K.
    Ahmed, Maqsood
    Marzouk, Adel A.
    El-Moghazy, Samir M.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O295 - +
  • [10] Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)chloroquine analogues
    Cunico, W
    Cechinel, CA
    Bonacorso, HG
    Martins, MAP
    Zanatta, N
    de Souza, MVN
    Freitas, IO
    Soares, RPP
    Krettli, AU
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 649 - 653